NeuroOne Medical Technologies Corporation
NMTC
$0.652
$0.04858.04%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.27M | 272.30K | 825.80K | 1.38M | 977.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.27M | 272.30K | 825.80K | 1.38M | 977.60K |
| Cost of Revenue | 2.52M | 1.24M | 1.74M | 2.26M | 2.19M |
| Gross Profit | 754.70K | -972.60K | -912.80K | -883.10K | -1.22M |
| SG&A Expenses | 2.04M | 1.84M | 1.88M | 2.00M | 2.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -3.00M | -- | -- | -- | -- |
| Total Operating Expenses | 1.56M | 3.09M | 3.62M | 4.26M | 4.37M |
| Operating Income | 1.71M | -2.82M | -2.79M | -2.89M | -3.39M |
| Income Before Tax | 1.79M | -3.35M | -2.77M | -2.86M | -3.34M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.79M | -3.35M | -2.77M | -2.86M | -3.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.79M | -3.35M | -2.77M | -2.86M | -3.34M |
| EBIT | 1.71M | -2.82M | -2.79M | -2.89M | -3.39M |
| EBITDA | 1.78M | -2.75M | -2.73M | -2.83M | -3.33M |
| EPS Basic | 0.06 | -0.11 | -0.10 | -0.11 | -0.14 |
| Normalized Basic EPS | 0.04 | -0.07 | -0.06 | -0.07 | -0.09 |
| EPS Diluted | 0.06 | -0.11 | -0.10 | -0.11 | -0.14 |
| Normalized Diluted EPS | 0.04 | -0.07 | -0.06 | -0.07 | -0.09 |
| Average Basic Shares Outstanding | 30.84M | 29.81M | 27.35M | 25.91M | 24.00M |
| Average Diluted Shares Outstanding | 30.88M | 29.81M | 27.35M | 25.91M | 24.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |